Free Republic

Watertown, MA—Scientists at Boston Biomedical Research Institute (BBRI) and the University of Pennsylvania have found that combining two chemicals, one of which is the green tea component EGCG, can prevent and destroy a variety of protein structures known as amyloids. Amyloids are the primary culprits in fatal brain disorders such as Alzheimer's, Huntington's, and Parkinson's diseases. Their study, published in the current issue of Nature Chemical Biology (December 2009), may ultimately contribute to future therapies for these diseases. "These findings are significant because it is the first time a combination of specific chemicals has successfully destroyed diverse forms of amyloids...

Alzheimer's caused by cold sore virus? In a connection that sounds borderline preposterous, links have been accumulating between Alzheimer's disease and cold sores....Cold sores are caused by the herpes simplex virus type 1, a type that should not be confused with herpes symplex virus type 2 which is the cause of genital herpes. A growing body of research, suggests that the HSV-1 may also be responsible for the majority of Alzheimer's cases.... "There's clearly a very strong connection," says British researcher, Ruth Itzhaki, Ph.D., speaking one afternoon in her office at the University of Manchester, in northwestern England. A neurobiologist,...

Enlarge Caffeine treatment removed the beta amyloid plaques from the brains of the Alzheimer's mice. Credit: Photo courtesy of Florida Alzheimer's Disease Research Center Coffee drinkers may have another reason to pour that extra cup. When aged mice bred to develop symptoms of Alzheimer's disease were given caffeine - the equivalent of five cups of coffee a day - their memory impairment was reversed, report University of South Florida researchers at the Florida Alzheimer's Disease Research Center. Back-to-back studies published online today in the Journal of Alzheimer's Disease, show caffeine significantly decreased abnormal levels of the protein linked to...

In experiments with lab mice especially bred to develop symptoms of Alzheimer's disease, University of South Florida (USF) researchers at the Florida Alzheimer's Disease Research Center ADRC gave the aged animals the equivalent of the caffeine in five cups of coffee a day. The results? Their severe memory impairment was reversed. This study, along with other AD research by the same group of scientists, was just published in the Journal of Alzheimer's Disease. Both studies show that caffeine significantly decreased abnormal levels of beta amyloid (the protein linked to AD) in both the brains and blood of lab rodents who...

STOCKHOLM — Middle-aged people who drink moderate amounts of coffee significantly reduce their risk of developing Alzheimer's disease, a study by Finnish and Swedish researchers showed Thursday. "Middle-aged people who drank between three and five cups of coffee a day lowered their risk of developing dementia and Alzheimer's disease by between 60 and 65 percent later in life," said lead researcher on the project, Miia Kivipelto, a professor at the University of Kuopio in Finland and at the Karolinska Institute in Stockholm. The study, which was also conducted in cooperation with the National Public Health Institute in Helsinki and which...

A diagnostic compound that allows researchers to look into the brains of Alzheimer's patients will be used for the first time to gauge the effects of an experimental therapy for the disease. Called florbetaben, the diagnostic could also provide important insights into the role of beta amyloid, a protein that accumulates into plaques in the brains of patients with Alzheimer's disease and has been shown to be toxic to nerve cells. The compound is an 18F-radiolabelled tracer that binds specifically to deposits of beta amyloid, and can be measured using positron emission tomography (PET), a nuclear imaging technique which produces a three-dimensional image of...

You shouldn't stay up all night worrying about it, but a new study has found a connection between a lack of sleep and a biomolecule thought to be important in the development of Alzheimer's disease. In both humans and mice, levels of a peptide called amyloid-β rise during waking hours and decline during sleep, researchers have found. They also report that sleep-deprived mice are more prone to developing deposits of amyloid-β, called plaques, like those found in the brains of Alzheimer's patients. Although far from proven, the finding suggests that sleep disorders could be a risk factor for Alzheimer's. On...

LAGUNA WOODS, Calif. — The ladies in the card room are playing bridge, and at their age the game is no hobby. It is a way of life, a daily comfort and challenge, the last communal campfire before all goes dark. “We play for blood,” says Ruth Cummins, 92, before taking a sip of Red Bull at a recent game. “It’s what keeps us going,” adds Georgia Scott, 99. “It’s where our closest friends are.” In recent years scientists have become intensely interested in what could be called a super memory club — the fewer than one in 200 of...

News From The American Chemical Society, May 13, 200919 May 2009    Advance in detecting melamine-adulterated food Researchers in Indiana are reporting an advance toward faster, more sensitive tests for detecting melamine, the substance that killed at least 6 children and sickened 300,000 children in China who drank milk and infant formula adulterated with the substance. The improved tests may ease global concerns about food safety, the researchers say. Their report is scheduled for the May 27 issue of ACS' Journal of Agricultural and Food Chemistry, a bi-weekly publication. In the new study, Lisa Mauer and colleagues note that tests...

Canadian scientists have been inspired by analytical chemistry to attack Alzheimer's disease from all sides. Chris Orvig from the University of British Columbia, Vancouver, and colleagues made multifunctional compounds to target amyloid plaque formation, a possible cause of Alzheimer's disease. Amyloid plaques are protein clusters with metal ions that accumulate between neurons in Alzheimer's patients' brains. Orvig designed his compounds to combat the protein misfolding and metal-peptide interactions involved in amyloid plaque production as well as the oxidative stress that occurs (a condition that damages cells, caused by excess free radicals). 'We aren't 100 per cent sure about the order...

UK and Dutch scientists have mimicked an ancient Chinese culinary technique of preserving eggs to study how proteins cause disease. Erika Eiser from the University of Cambridge and colleagues looked at how proteins in egg whites altered during this preservation process. The Chinese method involves wrapping raw eggs in an alkaline paste of lime, clay, salt, ash and tea and storing these so-called century eggs for several months. Eiser modified the method by incubating a boiled egg in a strong alkaline sodium hydroxide-salt solution for up to 26 days. Hard boiled egg whites become a transparent gel in an alkaline...

Non-infectious form of prion protein could cause brain degeneration. Prion proteins may react with amyloid-(beta) peptides inside the brain cells of Alzheimer's patients.Thomas Deerinck NCMIR/Science Photo Library Non-infectious prion proteins found in the brain may contribute to Alzheimer's disease, researchers have found. The surprising new results, reported this week in Nature1, show that normal prion proteins produced naturally in the brain interact with the amyloid-(beta) peptides that are hallmarks of Alzheimer's disease. Blocking this interaction in preparations made from mouse brains halted some neurological defects caused by the accumulation of amyloid-(beta) peptide. It was previously thought that only infectious prion...

Did Grandma seem forgetful at the holiday parties last month? It could be time to put her on a diet. Sharply reducing calories improves memory in older adults, according to one of the first studies of dietary restriction and cognitive function in humans. Research on the benefits of an extremely low-calorie diet stretches back to the 1930s, when scientists found that rats lived up to twice as long when they nibbled less than control animals. Since then, some studies with rodents and nonhuman primates have shown that this spare diet, known as calorie restriction, improves some markers of diabetes and...

Clioquinol inhibits action of the CLK1 aging gene, may alleviate Alzheimer'sRecent animal studies have shown that clioquinol – an 80-year old drug once used to treat diarrhea and other gastrointestinal disorders – can reverse the progression of Alzheimer's, Parkinson's and Huntington's diseases. Scientists, however, had a variety of theories to attempt to explain how a single compound could have such similar effects on three unrelated neurodegenerative disorders. Researchers at McGill University have discovered a dramatic possible new answer: According to Dr. Siegfried Hekimi and colleagues at McGill's Department of Biology, clioquinol acts directly on a protein called CLK-1, often informally...

Talk of the Nation, November 7, 2008 · A new study published in the Journal of Neuroscience shows that mice treated with large doses of vitamin B3 performed better on memory tests. Kim Green, one of the authors of the study, explains whether this discovery could have any application for treating Alzheimer's in humans.

... We present a novel computational approach for describing the formation of oligomeric assemblies at experimental concentrations and timescales. We propose an extension to the Markovian state model approach, where one includes low concentration oligomeric states analytically. This allows simulation on long timescales (seconds timescale) and at arbitrarily low concentrations (e.g., the micromolar concentrations found in experiments), while still using an all-atom model for protein and solvent. As a proof of concept, we apply this methodology to the oligomerization of an Abeta peptide fragment (Abeta 21–43). Abeta oligomers are now widely recognized as the primary neurotoxic structures leading to Alzheimer's...

The finding could open the door to improved treatments. Researchers say they've discovered a gene that may make it easier for people to develop Alzheimer's disease, and it could become a target for drug treatments. "This new work not only provides a better understanding of the mechanism leading to the disease, but identifies a risk factor as an important target for therapy," said Philippe Marambaud, an assistant professor of pathology at the Albert Einstein College of Medicine in New York City and member of an international team of scientists that released its findings Wednesday. Alzheimer's disease, which causes senility and...

Ramona Lamascola thought she was losing her 88-year-old mother to dementia. Instead, she was losing her to overmedication. Last fall her mother, Theresa Lamascola, of the Bronx, suffering from anxiety and confusion, was put on the antipsychotic drug Risperdal. When she had trouble walking, her daughter took her to another doctor — the younger Ms. Lamascola’s own physician — who found that she had unrecognized hypothyroidism, a disorder that can contribute to dementia. Theresa Lamascola was moved to a nursing home to get these problems under control. But things only got worse. “My mother was screaming and out of it,...

The leader of the team that made the discovery, Professor Christopher Rowe of the Austin Hospital in Melbourne, says early diagnosis and treatment presents medical practitioners with the best opportunity to delay the onset of Alzheimer's. "While the discovery is at an experimental stage, this work places Australia at the forefront of neuro-imaging in Alzheimer's disease," Professor Rowe says. A 2004 Access Economics report calculated that if the average age of onset of Alzheimer's was raised by just five months, cumulative savings of A$1.3 billion would be realised by 2020 rising to A$6.6 billion by 2040. Alzheimer's disease is characterised...

SYDNEY, June 20, 2008 (LifeSiteNews.com) - Euthanasia provider and activist Dr. Philip Nitschke has released controversial statements that essentially instruct anyone who believes they are suffering from Alzheimer's disease to avoid obtaining a diagnosis in favour of seeking a doctor who can help them commit suicide as quickly as possible. These comments come on the heels of yesterday's New South Wales jury ruling that convicted two women for the "euthanasia" death of a 71-year old Sydney man, Graeme Wylie, in 2006. As reported by the news service, The Age, Shirley Justins, the wife of Wylie, was convicted of manslaughter for...

TAMPA, FL, March 27, 2008 (LifeSiteNews.com) - Targeted immune suppression using human umbilical cord blood cells may improve the pathology associated with Alzheimer's disease, a new study in a mouse model of this currently untreatable neurodegenerative condition reports. The study, led by researchers at the University of South Florida, is published online in the peer-reviewed journal Stem Cells and Development (http://www.liebertpub.com/scd).Following a series of low-dose infusions of human umbilical cord blood cells into mice with Alzheimer's-like disease, the amount of amyloid-ß and ß-amyloid plaques - hallmarks of Alzheimer's pathology in the brain - was reduced 62 percent. Amyloid-ß induces...

Differential regulation of dynein and kinesin motor proteins by the microtubule associated protein tau. The Penn group found that dynein, which carries loads towards the interior of the nerve cell, maneuvers around tau; whereas, kinesin, which carries loads towards the outside of the nerve cell, detaches when it encounters tau. Credit: Credit: Ram Dixit, PhD, University of Pennsylvania School of Medicine Researchers at the University of Pennsylvania School of Medicine discovered that proteins carrying chemical cargo in nerve cells react differently when exposed to the tau protein, which plays an important role in Alzheimer’s disease. Dynein and kinesin proteins transport...

As we approach one million PLAYSTATION 3 consoles participating in the Folding@Home program, we continue to improve the FAH client. With the new Firmware v2.1 we also prepared an updated version of FAH, which can soon be automatically downloaded by clicking on the FAH icon. This updated version includes the following new features: If you happen to be one of the people that wants to leave their machine running after they finished their late-night gaming session, but wish to shut it down after a limited period of time, we have a great tip for you: Go to Settings menu, select...

My husband, at 74, is the baby of his bridge group, which includes a woman of 85 and a man of 89. This challenging game demands an excellent memory (for bids, cards played, rules and so on) and an ability to think strategically and read subtle psychological cues. Never having had a head for cards, I continue to be amazed by the mental agility of these septua- and octogenarians. The brain, like every other part of the body, changes with age, and those changes can impede clear thinking and memory. Yet many older people seem to remain sharp as a...

Even seniors fortunate enough to avoid the horrors of Alzheimer's disease typically experience some declines in memory and other cognitive abilities. Little is known about why this happens, but a new study suggests that cognitive declines in healthy older adults may result when brain regions that normally work together become out of sync, perhaps because the connections between them break down. A team led by Harvard neuroscientists Jessica Andrews-Hanna and Randy Buckner used functional magnetic resonance imaging (fMRI) to monitor brain activity in 38 young adults, mostly 20-somethings, and 55 older adults, age 60 or above. The researchers focused on...

Scientists reported progress today toward one of medicine’s long-sought goals: the development of a blood test that can accurately diagnose Alzheimer’s disease, and even do so years before truly debilitating memory loss. A team of scientists, based mainly at Stanford University, developed a test that was about 90 percent accurate in distinguishing the blood of people with Alzheimer’s from the blood of those without the disease. The test was about 80 percent accurate in predicting which patients with mild memory loss would go on to develop Alzheimer’s disease two to six years later. Outside experts called the results, published online...

A ruling by the national drug watchdog to limit access to an Alzheimer’s drug has been upheld by the High Court. The drug company Eisai challenged the National Institute for Health and Clinical Excellence (NICE) over its guidance that for most patients Eisai’s drug Aricept was not a cost-effective use of NHS resources. This was the first legal challenge to a NICE judgment and, except in one aspect, it was a failure. In the High Court yesterday Mrs Justice Dobbs ruled that on five out of six issues raised by Eisai and the Alzheimer’s Society, the challenge failed. NICE’s decision,...

DEGENERATIVE brain diseases, including Alzheimers, could one day be treated with drugs that can reverse distressing loss of memory, according to a study released Sunday. The very term "memory loss'' could be a misnomer in such cases, suggests the study, published in British journal Nature: that cherished recollection of a first kiss, seemingly destroyed by disease, may have simply been rendered inaccessible by obstructed neural pathways. In laboratory experiments, mice suffering the type of brain damage which in humans typically leads to dementia - robbing victims of the ability to remember past events or even to recognize loved ones -...

Immune Antibodies Penetrate Neurons To Clear Alzheimer's-Linked Amyloid - Discovery Could Advance Treatment For Alzheimer's, Immune Diseases Researchers at Weill Cornell Medical College have gotten much closer to understanding how immune-based therapies can treat Alzheimer's disease -- by studying how antibodies go inside brain cells to reduce levels of Alzheimer's-linked amyloid peptides that form plaques between neurons. "This internalization and activity of the antibody within the cell was a big surprise and something we really haven't appreciated in neurological medicine. It gives us new hope for the use of immunotherapy against Alzheimer's, while casting intriguing new light on other disease...

A diet rich in a type of omega-3 fatty acid can help prevent Alzheimer's disease, and a newly discovered molecule might block enzymes in the brain that lead to plaque formations -- a hallmark of the progressive brain disorder -- two new studies suggest. In one of those studies, at the University of California, Irvine, scientists used genetically engineered mice and it is reportedly the first to show that an omega-3 fatty acid known as docosahexaenoic acid, or DHA for short, can slow the accumulation of tau, a protein that leads to plaque and tangles in brain tissue seen in...

Ron Reagan, Jr., admitted Monday night that embryonic stem cell research will probably be absolutely useless in the quest to find a cure for Alzheimer's disease - throwing cold water on the big media's campaign to sell the controversial science as medically effective in battling the affliction that killed Reagan's father. "Alzheimer‘s is a disease, ironically, that probably won‘t be amenable to treatment through stem cell therapies," Reagan told MSBC's Chris Matthews. So why have he and his mother, former first lady Nancy Reagan, made stem cell research their cause celeb? "For people to suggest that [Nancy Reagan] shouldn’t support...

A substance found in fish oil may be associated with a significantly reduced risk of developing Alzheimer’s and other dementias, researchers reported yesterday. The scientists found that people with the highest blood levels of an omega-3 fatty acid called docosahexaenoic acid, or DHA, were about half as likely to develop dementia as those with lower levels. The substance is one of several omega-3 polyunsaturated fatty acids found in fatty fish and, in small amounts, in some meats. It is also sold in fish oil or DHA supplements. The researchers looked for a reduced risk associated with seven other omega-3 fatty...

A cup of coffee may do more than help start your day. A new study suggests coffee may go a long way toward protecting your brain cells from the damage of Alzheimer's disease and several other neurological diseases. The research, which came from the Alzheimer's Institute in Florida, found coffee protects the brain. Other studies have found no difference in brain protection whether someone drinks caffeinated or decaf so the "protector" may be one of the 70 other chemicals found in a cup of joe. Some good news is that it's not too late to start enjoying a cup of...

ONE hundred years ago today, a 42-year-old German psychiatrist and neuropathologist named Alois Alzheimer shocked colleagues with his description of one woman’s autopsied brain. The woman was named Auguste Deter. Five years earlier, her husband had admitted her to Alzheimer’s psychiatric hospital in Frankfurt with a disturbing set of symptoms: memory trouble, aphasia (loss of the ability to use words), confusion, bursts of anger and paranoia. She had become a danger to herself in the kitchen and needed constant care. Alzheimer found his new patient sitting on a bed with a helpless expression. “What is your name?” he asked. “Auguste,”...

What are the costs of a progressive brain disease on an aging society? At the 10th International Conference on Alzheimer's Disease and Related Disorders (ICAD), in Madrid in July 2006, Dr. Anders Wimo of the Stockholm Gerontology Research Center and Aging Research Center at Karolinska Institute, Sweden, said worldwide costs of dementia care (combined direct and informal costs) is around $248 billion annually. This overlooks the fact many suffer the ill effects and still receive no care and that our aging population is growing at a breathtaking rate. "These startling cost estimates for Alzheimer's care clearly illustrate the great challenges...

Scientists Create Brain Cells, Predict Possible Rapid Development of Treatments for Alzheimers and Parkinson's WASHINGTON, June 14, 2005 (LifeSiteNews.com) - American researchers have found a method of growing batches, or lines, of fully mature brain cells. This has often been predicted as the end of such neurological diseases as Parkinson’s, Alzheimer’s and Huntington’s. The ethical new technique mimics the brain’s own natural process of changing stem cells into neurons. For the moment, the research has been confined to mice, but the researchers are hopeful that their work can soon be transferred to human patients. Bjorn Scheffler, a neuroscientist at Florida...

AP MEDICAL WRITER WASHINGTON -- Scientists have discovered molecular janitors that clear away a sticky gunk blamed for Alzheimer's disease - until they get old and quit sweeping up. The finding helps explain why Alzheimer's is a disease of aging. More importantly, it suggests a new weapon: drugs that give nature's cleanup crews a boost. "It's a whole new way of thinking in the Alzheimer's field," said Dr. Andrew Dillin, a biologist at California's Salk Institute for Biological Studies who led the new research. The discovery, published Thursday by the journal Science, was made in a tiny roundworm called C....

Health and Science Correspondent WASHINGTON, Aug 7 (Reuters) - An Alzheimer's pill that helps slow the brain damage caused by the disease may also protect against the effects of nerve gases and pesticides, U.S. researchers reported on Monday. They said the drug, marketed under the name Reminyl and Razadyne, completely protected guinea pigs against the nerve agents soman and sarin, as well as toxic amounts of pesticides. They gave the animals high doses of the poisons and treated them with Reminyl, known generically as galantamine, along with atropine, often given as an antidote for organophospate pesticides such as paraoxon. "To...

A blood product normally used to treat immune disorders and a type of leukemia may also slow or stop mental decline in people with Alzheimer’s disease, researchers reported yesterday at an Alzheimer’s conference in Madrid. The product is called IVIg (pronounced EYE-vig), for intravenous immunoglobulin, also known as gamma globulin. Made from pooled blood plasma, it is a thick soup of antibodies, the proteins made by the immune system to get rid of unwanted substances. It has been used for 30 years for other diseases and is dripped into a vein like a transfusion. But the findings in Alzheimer’s are...

Several new studies suggest that diabetes increases the risk of Alzheimer’s disease, adding to a store of evidence that links the disorders. The studies involve only Type 2 diabetes, the most common type, which is usually related to obesity. The connection raises an ominous prospect: that increases in diabetes, a major concern in the United States and worldwide, may worsen the rising toll from Alzheimer’s. The findings also add dementia to the cloud of threats that already hang over people with diabetes, including heart disease, strokes, kidney failure, blindness and amputations. But some of the studies also hint that measures...

Alzheimer's disease, a dreaded specter for many elderly, is far more likely to strike individuals with Down syndrome. Now, a study with a mouse model of Down syndrome may explain why. The work hints at potential targets for future drugs that fend off dementia--in people with Down syndrome and in the general population too. Down syndrome is caused by an extra copy of chromosome 21. It affects roughly 1 in 800 people, causing mild to moderate mental retardation and a range of other health problems, including early-onset dementia. By age 40, the brains of all people with Down syndrome develop...

An arthritis drug shows promise in a small, experimental study targeting a root cause of Alzheimer's -- inflammation in the brain. WALTER Skotchdopole worked for 20 years as a police officer and 20 years in the film industry before succumbing to the relentless decline of Alzheimer's disease. In his prime, he joked with everyone he met. By his early 70s, he had become a shell of his former self. "He's there, but he's not," says his son James Skotchdopole. "There's no real interaction, no real stake in life." Walter Skotchdopole had tried several drugs, with no noticeable improvement. But when...

P-I REPORTER Determining your chances of developing dementia or Alzheimer's disease could be as simple as timing your walk, testing the strength of the grip of your dominant hand and checking your balance when standing still. That's what a Seattle-based research team determined during a six-year study of 2,288 people 65 and older. Dr. Eric Larson, director of Group Health's Center for Health Studies, said the study started in 1994 and is ongoing, but the analysis of the first six years was published in Monday's Archives of Internal Medicine. When the study began, none of the participants showed signs of...

Plaque on the brain doesn't sound good, but the condition may not be as crippling as once thought. Mice with the gummy deposits-- usually a symptom of Alzheimer's disease--can still have normal memories, according to a new study. The findings suggest a novel target for Alzheimer's drugs and a new way of understanding how the disease ravages the brain, say the researchers. Alzheimer's is thought to be caused in part by sticky build up of a toxic peptide called â amyloid, produced when the amyloid precursor protein (APP) is cut in two. Recent research, however, has shown that early signs...

Close window Published online: 21 April 2006; | doi:10.1038/news060417-10 Death of Alzheimer victim linked to aluminium pollutionBrain autopsy of pollution victim rekindles contaminant fears.Michael Hopkin Aluminum can accumulate in the twists of deformed proteins that characterize Alzheimer's disease.© SPL Fears of a link between aluminium and Alzheimer's disease have been reignited by the case of a British woman who died of the illness 16 years after an industrial accident polluted her local drinking water. An autopsy on Carole Cross's brain showed that she was suffering from a rare form of early-onset Alzheimer's when she died in May 2004, and...

An unusual number of deaths among patients in a large study of Aricept, the most popular drug to treat Alzheimer's disease, is raising concern among federal drug officials and some disease experts. In the study, of 974 patients who suffered from dementia related to heart disease, 11 deaths occurred among the patients taking Aricept, while no deaths occurred among those taking dummy pills. The Food and Drug Administration is examining the results of the study, said Susan Bro, an agency spokeswoman. The agency undertook a quick review of earlier Aricept studies and found no cause for concern, Ms. Bro said....

AP Biotechnology Writer SAN FRANCISCO — It's tragedy enough that Pat Williams' mother has Alzheimer's disease. But Williams is also terrified because her chances of inheriting the disease are much better than average. So Williams eagerly enrolled her 90-year-old mother last year in a massive, 1,600-patient, 18-month clinical trial testing an experimental drug made by the biotechnology company Myriad Genetics Inc. The drug, called Flurizan, slowed the mind-robbing disease in some of the 128 patients with mild Alzheimer's participating in a smaller test. Based on those results, the company has gambled millions of research dollars on the largest-ever Alzheimer's drug...

MONTREAL, Feb. 17 (UPI) -- Canadian researchers said Friday they have uncovered a natural defense mechanism to Alzheimer's disease. Not surprisingly, it involves stem cells -- those derived from bone marrow. In Alzheimer's patients, plaque forms in the brain, but the brain's resident immune cells, called microglia, can't fight off the substance. The plaque can then kill off the brain's neurons, or nerve cells. However, microglia harvested from bone marrow stem cells do appear capable of defeating the plague, said researchers from the Faculty of Medicine at Université Laval and the research centre at Centre hospitalier universitaire de Québec, Canada....

ASSOCIATED PRESS NEW YORK -- Older anti-psychotic drugs are no safer and might even be worse for the elderly than newer ones that the government warned about earlier this year - both raise the risk of death, a study suggests. The Food and Drug Administration asked drug makers in April to add warnings to the labels of newer anti-psychotics because studies showed the drugs nearly doubled the risk of death for older patients with dementia. These drugs are widely used to treat the aggressive behavior, delusions and hallucinations sometimes experienced by those with dementia, including Alzheimer's disease. Researchers at Harvard's...

SITTING the other day in front of Picasso's rapturous "Girl Before a Mirror" at the Museum of Modern Art, Rueben Rosen wore the dyspeptic look of a man with little love for modern art. But the reason he gave for disliking the painting was not one you might expect to hear from an 88-year-old former real estate broker. "It's like he's trying to tell a story using words that don't exist," Mr. Rosen said finally of Picasso, fixing the painter's work with a critic's stare. "He knows what he means, but we don't."This chasm of understanding is one that Mr....